Search | Aplastic Anemia and MDS International Foundation


Search results

  1. Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab.

    ... and pure red cell aplasia (PRCA) patients with daclizumab , a humanized monoclonal antibody to the interleukin-2 ... events were transient rashes and arthralgias. Daclizumab is safe and effective, and produces lengthy remissions in patients ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Recent Developments in Drug Therapy for Aplastic Anemia

    ... with hATG fails or when hATG is unavailable. Front-line daclizumab can be considered for nonsevere AA (NAA); however, data is ... rATG is reserved for salvage therapy. Front-line use of daclizumab has been studied in NAA patients, but additional prospective trials ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. Antibodies in the treatment of aplastic anemia.

    ... have emerged: porcine ATG, alemtuzumab , daclizumab , and rituximab. Experience with these antibodies is limited to a ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. Daclizumab

    ... of organ rejection. Currently, researchers are studying daclizumab for treating aplastic anemia to determine whether it ...

    Drug last updated 03/26/2016 - 8:14pm.

  5. Drugs

    ... C ytoxan daclizumab Z enapax ...

    Page last updated 03/02/2016 - 9:11am.